An active medical device means any medical device relying for its functioning on a source of electrical energy or any source of power other than that directly generated by the human body or gravity. There is an increasing use of implantable cardiac devices in patients with chronic heart failure. These devices have a number of functions including pacing, defibrillation, and data collection. In addition, new generations of investigational stand-alone implantable hemodynamic monitoring systems are making their way toward clinical practice.
Here are the leading companies operating in this active implantable devices market –
Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland. The company designs, manufactures, and sales medical devices. The company offers its products under four operating business segments i.e. cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. The cardiac and vascular group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices.
The company has a strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa with its 30 subsidiaries.
Founded in 1979 and headquartered in Massachusetts, U.S.; Boston Scientific Corporation operates in developing, manufacturing, and marketing medical devices for use in various interventional medical specialties worldwide. The company operates into three operating business segments i.e. Cardiovascular, Rhythm Management, and MedSurg. Cardiovascular segment offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems and implantable cardiac resynchronization therapy pacemaker systems used to treat & detect abnormally fast heart rhythms & heart failure.
With the strong distribution network and more than 35 subsidiaries including Cardiac Pacemakers, Inc. and Boston Scientific Japan K.K; the company has a strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Founded in 1963 and headquartered in Berlin, Germany; BIOTRONIK SE & CO., KG operates in designing, developing, manufacturing, and marketing cardio and endovascular medical devices in Germany and internationally. The company offers products for bradycardia therapy, including pacemakers, leads, and external devices; tachyarrhythmia therapy, such as ICDs, leads, and external devices; ablation and diagnostic catheters, and temporary pacing for electrophysiology for cardiac resynchronization.
The company has its strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Meticulous Research in its latest publication on Active Implantable Devices Market has predicted the growth of 6.7% during the forecast year 2027-2022
Sorin Group and Cyberonics are merged together to create a new premier global medical technology company LivaNova PLC in February 2015. The company operates through three business segments namely neuromodulation, cardiac surgery, and cardiac rhythm management. Cardiac Rhythm Management segment offers implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and patient management tools primarily for electrophysiologists, implanting cardiologists, heart failure specialists, and cardiac surgeons.
With more than 35 subsidiaries including LivaNova Austria GmbH, Cyberonics, Inc., and California Medical Laboratories, Inc.; the company has a strong geographic presence in North America, Europe, Asia-pacific, Latin America, and Middle East & Africa.
William Demant Holding A/S was founded in 1904 and is headquartered in Denmark, Europe. The company operates in developing, manufacturing, and selling products and equipment designed to aid the hearing and communication of individuals. The company offers hearing devices and implants; diagnostic instruments; and personal communication systems which includes professional and consumer headsets for the gaming, mobile phone, call centre and office segments.
The company strong geographical presence in Denmark, rest of Europe, North America, Oceania, Asia, and other countries, with 17 subsidiaries including Oticon, Amplivox Ltd., and ListenUP Hearing Healthcare Canada, Inc.
Cochlear Ltd. founded in 1981, is headquartered in Sydney, Australia. The company operates in providing implantable hearing solutions. It offers cochlear implants, including Nucleus 6 system and Kanso sound processors. The company also provides Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses.
The company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, with its 40 subsidiaries including Nihon Cochlear Co., Ltd., Cochlear Medical Device Company India Pvt Ltd., and Cochlear German Holdings Pty Limited.
Sonova Holding AG was founded in 1947 and is headquartered in Switzerland, Europe. The company operates in designing, developing, manufacturing, and distributing hearing systems for adults and children with hearing impairment. The company offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services.
The company has strong geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, with its 19 subsidiaries including Sonova Service Center U.K. Limited and National Hearing Services Inc.
MED-EL was founded in 1970 and is headquartered in Austria, Europe. The company operates in manufacturing of medical devices for the treatment of various types and degrees of hearing loss. The company offers hearing implant solutions, such as cochlear, middle ear, electric acoustic stimulation hearing, and bone conduction implants.
The company has a strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Authoritative Research on the Active Implantable Devices Market
Need more information? Meticulous Research’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
Comprehensive report provides active implantable devices market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Please download PDF brochure and learn more: